Novavax (NVAX)

Add to Watchlists Create an Alert
4.58 +0.08  +1.78% NASDAQ Jul 30, 1:16PM BATS Real time Currency in USD
View Full Chart
NVAX Price Chart
View All Events

NVAX Events

Date Type Description
06/12/2014 Misc Annual General Meeting for Novavax Inc
05/07/2014 16:30 EDT Misc Novavax Inc 1Q2014 Earning Conference Call
05/07/2014 Earnings Novavax Inc 1Q2014 Earning Result. Estimate: -0.07.
03/10/2014 16:30 EDT Misc Novavax, Inc. Q4 2013 Earning Conference Call
03/10/2014 Earnings Novavax, Inc. Q4 2013 Earning Result. Estimate: -0.08.
11/07/2013 Earnings Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013. Estimate: -0.05.
11/07/2013 16:30 EDT Misc Novavax to Report Third Quarter 2013 Financial Results Conference Call
09/24/2013 Misc Novavax to Host an Analyst and Investor Update Call With Webcast
08/22/2013 Misc Novavax Acquires Isconova; Extended Public Tender Offer Period Closed
08/08/2013 08:30 EDT Misc Second Quarter 2013 Financial Conference Call
View All Performance Charts

NVAX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novavax is up 82.47% over the last year vs S&P 500 Total Return up 19.11%, Ophthotech up N/A, and Sarepta Therapeutics down 33.15%.

Get Quote for

PDF Report for NVAX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NVAX Pro Report PDF
Advertisement

Portfolio Strategies Featuring NVAX

Did Novavax make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NVAX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.novavax.com
  • IR Website: http://www.novavax.com/go.cfm?do=Page.View&pid=34
  • HQ Country: United States
  • HQ State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Novavax, Inc. is a clinical-stage biopharmaceutical company engaged in creating differentiated, value- upon current preventive options for various infectious diseases.

NVAX Excel Add-In Codes

  • Name: =YCI("NVAX","name")
  • Description: =YCI("NVAX","description")
  • Sector: =YCI("NVAX","sector")
  • Industry: =YCI("NVAX","industry")
  • Est. Current Fiscal Year End: =YCI("NVAX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.